Amgen EVP and CTO David M. Reese to retire June 30, 2026; roles redistributed

AMGEN INC

David M. Reese retires as EVP and CTO effective June 30, 2026; responsibilities split among Bradner, Gordon, Griffith starting June 1.
James Bradner becomes EVP of R&D, AI and Data; Sean Bruich named SVP and CTO.
Murdo Gordon takes EVP of Amgen Global Markets and Policy; Paul Burton remains Chief Medical Officer.
Reese joined Amgen in 2005, led R&D from 2018-2023, and served as inaugural CTO.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.